Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.

Asselin-Labat ML, Sutherland KD, Vaillant F, Gyorki DE, Wu D, Holroyd S, Breslin K, Ward T, Shi W, Bath ML, Deb S, Fox SB, Smyth GK, Lindeman GJ, Visvader JE.

Mol Cell Biol. 2011 Nov;31(22):4609-22. doi: 10.1128/MCB.05766-11. Epub 2011 Sep 19.

2.

Optimized cryopreservation of mouse sperm based on fertilization rate.

Bath ML.

J Reprod Dev. 2011 Feb;57(1):92-8. Epub 2010 Nov 10.

3.

Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.

Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, Metcalf D, Scott CL, Cory S.

Blood. 2010 Oct 28;116(17):3197-207. doi: 10.1182/blood-2010-04-281071. Epub 2010 Jul 14.

5.

Impaired lactation in mice expressing dominant-negative FADD in mammary epithelium.

Shackleton M, O'Reilly LA, Sutherland KD, Bath ML, Ellis S, Strasser A, Visvader JE, Lindeman GJ.

Dev Dyn. 2009 Apr;238(4):1010-6. doi: 10.1002/dvdy.21917.

6.

Deaf-1 regulates epithelial cell proliferation and side-branching in the mammary gland.

Barker HE, Smyth GK, Wettenhall J, Ward TA, Bath ML, Lindeman GJ, Visvader JE.

BMC Dev Biol. 2008 Oct 1;8:94. doi: 10.1186/1471-213X-8-94.

7.

Subversion of the Bcl-2 life/death switch in cancer development and therapy.

Adams JM, Huang DC, Strasser A, Willis S, Chen L, Wei A, van Delft M, Fletcher JI, Puthalakath H, Kuroda J, Michalak EM, Kelly PN, Bouillet P, Villunger A, O'Reilly L, Bath ML, Smith DP, Egle A, Harris AW, Hinds M, Colman P, Cory S.

Cold Spring Harb Symp Quant Biol. 2005;70:469-77.

PMID:
16869785
8.

MYC levels govern hematopoietic tumor type and latency in transgenic mice.

Smith DP, Bath ML, Metcalf D, Harris AW, Cory S.

Blood. 2006 Jul 15;108(2):653-61. Epub 2006 Mar 14.

9.

Overexpression of LMO4 induces mammary hyperplasia, promotes cell invasion, and is a predictor of poor outcome in breast cancer.

Sum EY, Segara D, Duscio B, Bath ML, Field AS, Sutherland RL, Lindeman GJ, Visvader JE.

Proc Natl Acad Sci U S A. 2005 May 24;102(21):7659-64. Epub 2005 May 16.

10.
11.

VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia.

Egle A, Harris AW, Bath ML, O'Reilly L, Cory S.

Blood. 2004 Mar 15;103(6):2276-83. Epub 2003 Nov 20.

PMID:
14630790
12.
13.

Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins.

Adams JM, Huang DC, Puthalakath H, Bouillet P, Vairo G, Moriishi K, Hausmann G, O'Reilly L, Newton K, Ogilvy S, Bath ML, Print CG, Harris AW, Strasser A, Cory S.

Cold Spring Harb Symp Quant Biol. 1999;64:351-8. Review. No abstract available.

PMID:
11232307
14.

The proapoptotic BH3-only protein bim is expressed in hematopoietic, epithelial, neuronal, and germ cells.

O'Reilly LA, Cullen L, Visvader J, Lindeman GJ, Print C, Bath ML, Huang DC, Strasser A.

Am J Pathol. 2000 Aug;157(2):449-61.

15.

Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival.

Ogilvy S, Metcalf D, Print CG, Bath ML, Harris AW, Adams JM.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14943-8.

16.

Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment.

Ogilvy S, Metcalf D, Gibson L, Bath ML, Harris AW, Adams JM.

Blood. 1999 Sep 15;94(6):1855-63.

PMID:
10477714
17.
18.

A test of lymphoma induction by long-term exposure of E mu-Pim1 transgenic mice to 50 Hz magnetic fields.

Harris AW, Basten A, Gebski V, Noonan D, Finnie J, Bath ML, Bangay MJ, Repacholi MH.

Radiat Res. 1998 Mar;149(3):300-7.

PMID:
9496894
19.

Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment.

Ogilvy S, Elefanty AG, Visvader J, Bath ML, Harris AW, Adams JM.

Blood. 1998 Jan 15;91(2):419-30.

PMID:
9427694
20.

Deregulation of cell survival in lymphomagenesis.

Harris AW, Strasser A, Elefanty AG, Bath ML, Cory S.

Leukemia. 1997 Apr;11 Suppl 3:383-4.

PMID:
9209398
21.

Lymphomas and plasmacytomas in transgenic mice involving bcl2, myc and v-abl.

Harris AW, Strasser A, Bath ML, Elefanty AG, Cory S.

Curr Top Microbiol Immunol. 1997;224:221-30. No abstract available.

PMID:
9308245
22.

Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research.

Strasser A, O'Connor L, Huang DC, O'Reilly LA, Stanley ML, Bath ML, Adams JM, Cory S, Harris AW.

Behring Inst Mitt. 1996 Oct;(97):101-17. Review.

PMID:
8950469
23.

Overexpressed max is not oncogenic and attenuates myc-induced lymphoproliferation and lymphomagenesis in transgenic mice.

Lindeman GJ, Harris AW, Bath ML, Eisenman RN, Adams JM.

Oncogene. 1995 Mar 2;10(5):1013-7.

PMID:
7898919
24.

Perturbed development of T and B cells in mice expressing an Hlx homeobox transgene.

Allen JD, Harris AW, Bath ML, Strasser A, Scollay R, Adams JM.

J Immunol. 1995 Feb 15;154(4):1531-42.

PMID:
7836739
25.

scl, a gene frequently activated in human T cell leukaemia, does not induce lymphomas in transgenic mice.

Robb L, Rasko JE, Bath ML, Strasser A, Begley CG.

Oncogene. 1995 Jan 5;10(1):205-9.

PMID:
7824274
26.

Cyclin D1 as the putative bcl-1 oncogene.

Harris AW, Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Adams JM.

Curr Top Microbiol Immunol. 1995;194:347-53. Review. No abstract available.

PMID:
7895508
27.

Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene.

Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM.

EMBO J. 1994 May 1;13(9):2124-30.

28.

bmi-1 transgene induces lymphomas and collaborates with myc in tumorigenesis.

Haupt Y, Bath ML, Harris AW, Adams JM.

Oncogene. 1993 Nov;8(11):3161-4.

PMID:
8414519
29.

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease.

Strasser A, Whittingham S, Vaux DL, Bath ML, Adams JM, Cory S, Harris AW.

Proc Natl Acad Sci U S A. 1991 Oct 1;88(19):8661-5.

30.

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.

Strasser A, Harris AW, Bath ML, Cory S.

Nature. 1990 Nov 22;348(6299):331-3.

PMID:
2250704
31.

An E mu-v-abl transgene elicits plasmacytomas in concert with an activated myc gene.

Rosenbaum H, Harris AW, Bath ML, McNeall J, Webb E, Adams JM, Cory S.

EMBO J. 1990 Mar;9(3):897-905.

32.

Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice.

Strasser A, Harris AW, Vaux DL, Webb E, Bath ML, Adams JM, Cory S.

Curr Top Microbiol Immunol. 1990;166:175-81. No abstract available.

PMID:
2073796
33.

Lymphoid tumorigenesis by v-abl and BCR-v-abl in transgenic mice.

Harris AW, Bath ML, Rosenbaum H, McNeall J, Adams JM, Cory S.

Curr Top Microbiol Immunol. 1990;166:165-73. No abstract available.

PMID:
2073795
34.
35.

The transgenic window on lymphoid malignancy.

Adams JM, Harris AW, Vaux DL, Alexander WS, Rosenbaum H, Klinken SP, Strasser A, Bath ML, McNeall J, Cory S.

Princess Takamatsu Symp. 1989;20:297-309.

PMID:
2518688
36.

Monoclonal antibodies to bovine major histocompatibility system antigens.

Mackie JT, Bath ML, Stear MJ, Davis WC.

Exp Clin Immunogenet. 1989;6(2):179-84.

PMID:
2517028
38.

Hexachlorophene toxicity in dogs.

Bath ML.

J Small Anim Pract. 1978 Apr;19(4):241-4. No abstract available.

PMID:
651327
39.

Adrenocortical insufficiency in the dog.

Bath ML, Hill FW.

Aust Vet J. 1978 Mar;54(3):128-32.

PMID:
687264
40.

Osteochondritis dissecans of the distal humerus in a dog.

Wood AK, Bath ML, Mason TA.

Vet Rec. 1975 May 31;96(22):489-90. No abstract available.

PMID:
1136117
41.

Spontaneous pneumomediastinum in the racing Greyhound.

Jones BR, Bath ML, Wood AK.

J Small Anim Pract. 1975 Jan;16(1):27-32. No abstract available.

PMID:
1117704

Supplemental Content

Support Center